Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scarring alopecia causes permanent hair loss, and treatment aims to reduce inflammation and stop it from getting worse.

A new treatment using hydroxychloroquine, hyaluronidase, and steroids may improve hair loss from dermal filler complications.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Following treatment plans is crucial to prevent worsening skin and hair conditions.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

New technologies may improve topical treatments for hair loss.

Multiphoton microscopy can effectively distinguish between scarring and non-scarring alopecia.

Treatment improved some symptoms but not all.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Tinea can cause scarring alopecia in children, and fungal culture is crucial for diagnosis.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Exosome therapy shows promise for treating hair loss but needs more research and standardization.

Low-dose oral minoxidil significantly improves hair density in non-scarring alopecia.

Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.

Tailored combination therapy improves non-scarring alopecia outcomes.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

New treatments are needed for non-scarring alopecia due to current limitations.

Current treatments for non-scarring alopecia have limited effectiveness and side effects, while natural remedies may offer safer alternatives but need more research.